News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
344 Results
Type
Article (24)
Press Release (320)
Section
Business (143)
Deals (15)
Drug Development (57)
FDA (5)
Job Trends (6)
News (197)
Policy (17)
Tag
Academia (2)
Alliances (13)
Alzheimer's disease (1)
Approvals (7)
Best Places to Work (6)
Clinical research (49)
COVID-19 (9)
Diagnostics (1)
Earnings (109)
Events (91)
FDA (8)
GLP-1 (1)
Government (3)
Healthcare (2)
Infectious disease (9)
IPO (13)
Legal (1)
Medical device (2)
Medtech (2)
Mergers & acquisitions (2)
Neuroscience (1)
NextGen Class of 2024 (4)
People (26)
Phase I (16)
Phase II (37)
Phase III (25)
Pipeline (1)
Postmarket research (2)
Preclinical (1)
Real estate (1)
Regulatory (16)
Startups (1)
United States (13)
Date
Last 7 days (1)
Last 30 days (2)
Last 365 days (40)
2024 (39)
2023 (43)
2022 (61)
2021 (61)
2020 (55)
2019 (11)
2017 (16)
2016 (2)
2015 (31)
2014 (20)
2011 (1)
2010 (1)
Location
Asia (218)
Australia (2)
Europe (21)
Massachusetts (12)
Missouri (1)
344 Results for "mediwound".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MediWound to Report Third Quarter 2024 Financial Results
November 13, 2024
·
1 min read
Press Releases
MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update
November 26, 2024
·
18 min read
Press Releases
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
·
1 min read
Business
MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
MediWound Ltd., the global leader in next-generation enzymatic therapeutics for tissue repair, announced financial results for the first quarter ended March 31, 2024, and provided a corporate update.
May 29, 2024
·
14 min read
Press Releases
MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx® Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025
December 17, 2024
·
8 min read
Business
MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
MediWound Ltd. today announced that the Company will release its financial results for the fourth quarter and full year ended December 31, 2023 on Thursday, March 21, 2024.
March 14, 2024
·
2 min read
Press Releases
MediWound to Report Second Quarter 2024 Financial Results
August 2, 2024
·
1 min read
Business
MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
MediWound Ltd., the global leader in next-generation enzymatic therapeutics for tissue repair, announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.
March 21, 2024
·
17 min read
Press Releases
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 3, 2024
·
1 min read
Press Releases
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
October 10, 2024
·
6 min read
1 of 35
Next
